Joris Winderickx

Corporate Officer/Principal bei reMYND NV

Commercial Services

Consumer Services

Health Technology

Aktive Positionen von Joris Winderickx

Unternehmen	Position	Beginn	Ende
reMYND NV reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium.	Corporate Officer/Principal	30.05.2012	-
	Direktor/Vorstandsmitglied	01.01.2002	30.05.2012
	Gründer	09.11.2009	-

Unternehmen	Position	Beginn	Ende
Royal Flemish Chemical Society	Gründer	-	-
ADx NeuroSciences NV ADx NeuroSciences NV BiotechnologyHealth Technology ADx NeuroSciences NV develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. The company was founded in 2011 by Paul Appermont, Koen Dewaele, Hugo Vanderstichele and Eugeen Vanmechelen and is headquartered in Ghent, Belgium.	Direktor/Vorstandsmitglied	-	-
Katholieke Universiteit Leuven	Corporate Officer/Principal	-	-

Katholieke Universiteit Leuven

Doctorate Degree

International

Belgien

Operativ

Director/Board Member	2
Founder	2
Corporate Officer/Principal	2

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	3
reMYND NV reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium.	Commercial Services
Royal Flemish Chemical Society
ADx NeuroSciences NV ADx NeuroSciences NV BiotechnologyHealth Technology ADx NeuroSciences NV develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. The company was founded in 2011 by Paul Appermont, Koen Dewaele, Hugo Vanderstichele and Eugeen Vanmechelen and is headquartered in Ghent, Belgium.	Health Technology